News
Article
Time can be the most valuable asset in the drug and therapeutic development processes, especially in situations like the COVID-19…
View
Article
Today’s biotechnology scientists and companies are focused more on working together in the drug and therapy development process to benefit…
View
Press Release
Fargo, N.D. (May 4, 2021) – Pete Leland, a 20-year veteran of the biotechnology industry, has joined Genovac Antibody Discovery,…
View
Press Release
Genovac Fargo Fargo, N.D. (April 26, 2021) – A new biotechnology firm has chosen the North Dakota State Research and…
View
Article
The Forum, Fargo, N.D., recently featured Genovac Antibody Discovery’s launch in the North Dakota State University Research & Technology Park,…
View
Webinar
Genovac Research Scientist Patricia Odermatt and Anupam Singhal of Berkeley Lights talk for Digital Week’s Webcast Series on Antibodies, next-generation…
View
Webinar
On November 19 2020 Genovac took part in a webinar hosted by GEN. Panelists from Genovac presented case studies on…
View